Rare thoracic cancers, including peritoneum mesothelioma

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells

“…This pathology is related to a long exposure to asbestos mainly during occupational activities. In a recent study describing the incidence, prevalence and survival of 17,688 rare thoracic tumors in Europe, MPM was the most common with 19 cases per million people per year, and presented the lowest survival after five years (5%) [1]. Lung cancer is, overall, the most frequent cancer type worldwide, in terms of both incidence and mortality.…”

Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994–2009

“…That study showed an annual increase of 14.4% in MPM incidence (P=0.08) and predicted a large increase in incidence over coming decades. A geographical comparison study on the incidence of MPM and other mesotheliomas in patients diagnosed between 1978 and 2002, across five European regions, grouped the UK and ROI together as one region (3). That study concluded that the European age-standardized incidence of pleural and pericardial mesothelioma was highest in the UK and ROI, at 18.2 cases per million (cpm) per year, compared with 10 in Northern Europe, 12.1 in Central Europe, 3.3 in Eastern Europe and 11.4 in Southern Europe.…”

Seltene thorakale Tumorentitäten

“…Zum anderen standen dem Autor wesentliche Veröf-fentlichungen epidemiologischer Untersuchungen zu seltenen Tumorentitäten verschiedener internationaler Netzwerke sowie Übersichtsarbeiten zur Verfügung [5,16]. Hier sind im Speziellen Veröffent-lichungen von den durch die Europäische Kommission geförderten Projekte RareCare und RareCareNet sowie des weltweiten Rare Cancer Network und der North American Association of Central Cancer Registries (NAACCR) zu nennen [7,9,15,25].…”